Bayer AG PK Financials
We suggest to use Bayer AG PK fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Bayer AG PK is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate data for thirty-seven available fundamental indicators for Bayer AG PK, which can be compared to its peers.
Bayer |
Understanding current and past Bayer AG Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bayer AG's financial statements are interrelated, with each one affecting the others. For example, an increase in Bayer AG's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Bayer AG's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bayer AG PK. Check Bayer AG's Beneish M Score to see the likelihood of Bayer AG's management manipulating its earnings.
Bayer AG Stock Summary
Bayer AG competes with Novartis, Sanofi ADR, AstraZeneca PLC, GlaxoSmithKline PLC, and Bristol Myers. Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktienges is traded on OTC Exchange in the United States.Specialization | Healthcare, Biotechnology |
| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US0727303028 |
| CUSIP | 072730302 |
| Location | Germany |
| Business Address | Kaiser-Wilhelm-Allee 1, Leverkusen, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bayer.com |
| Phone | 49 214 30 1 |
| Currency | USD - US Dollar |
Bayer AG Key Financial Ratios
Bayer AG's financial ratios allow both analysts and investors to convert raw data from Bayer AG's financial statements into concise, actionable information that can be used to evaluate the performance of Bayer AG over time and compare it to other companies across industries.| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0576 | ||||
| Target Price | 15.0 | ||||
| Beta | 1.17 | ||||
| Z Score | 0.6 |
Bayer Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bayer AG's current stock value. Our valuation model uses many indicators to compare Bayer AG value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bayer AG competition to find correlations between indicators driving Bayer AG's intrinsic value. More Info.Bayer AG PK is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bayer AG PK is roughly 2.26 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bayer AG by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bayer AG's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Bayer Pink Sheet
If you are still planning to invest in Bayer AG PK check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bayer AG's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |